Explore stories from Atlantic Canada.
Barley Risotto and Kimchi: A Culinary Crossroads| SaltWire #food #cookingshorts #kimchiTOKYO - Health authorities searched a second Kobayashi Pharmaceutical factory in western Japan on Sunday after the company reported five deaths possibly tied to dietary supplements, an official said.
The cause of the deaths has not been confirmed, the official of Japan's Health and Welfare Ministry told Reuters. But"it is suspected that Beni-Koji may be the cause, so we have inspected two factories in two days." The health official said the ministry"would join hands with other ministries concerned to do our utmost to resolve the ongoing case while asking Kobayashi Pharma to cooperate as needed in looking into the case".
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Japan Inspects Kobayashi Pharma’s Plant After Product RecallJapanese authorities inspected Kobayashi Pharmaceutical Co.’s factory in Osaka after the drugmaker recalled some health supplements that have been linked to deaths and hospitalizations.
Read more »
Kobayashi Pharma Extends Drop on Report a User of Its Pills DiedShares of Japanese drugmaker Kobayashi Pharmaceutical Co. extended Monday’s slump after the company said it received a report one of the users of its recalled supplement pills died due to kidney disease.
Read more »
Japan Inspects Kobayashi Plant for Second Day Over Toxin ProbeJapanese authorities carried out a second day of inspections at Kobayashi Pharmaceutical Co.’s factory in Wakayama prefecture over safety concerns about the drugmaker’s health supplements, the Ministry of Health, Labor and Welfare said in a statement on Sunday.
Read more »
Bank of Japan's rate hike sets 'positive backdrop' for Japan equitiesFor the first time in 17 years, the Bank of Japan has hiked interest rates, up to a range of 0% to 0.1%. In response, the Yen has begun to slide against the ...
Read more »
Kobayashi factory searched over deaths possibly linked to supplementsExplore stories from Atlantic Canada.
Read more »
Novo Nordisk Agrees to Buy Cardior Pharma for Up to €1 BillionNovo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to €1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease.
Read more »